• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养不良是肝细胞癌(HCC)患者的预后因素。

Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC).

机构信息

Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Magdeburg, Germany.

Institute for Biometry and Medical Informatics, Otto-von-Guericke University, Magdeburg, Germany.

出版信息

Clin Nutr. 2015 Dec;34(6):1122-7. doi: 10.1016/j.clnu.2014.11.007. Epub 2014 Nov 18.

DOI:10.1016/j.clnu.2014.11.007
PMID:25434576
Abstract

BACKGROUND & AIMS: Malnutrition is a common, hence frequently underdiagnosed condition in patients with liver cirrhosis as well as in patients with cancer and has been shown to have a negative impact on survival in these patients. Frequently applied screening tools including anthropometric measurements or laboratory parameters to screen for malnutrition are not suitable for patients with liver cirrhosis with additional pathophysiological mechanisms leading to hypoalbuminemia and edema. Prospective data on the prevalence and prognostic impact of malnutrition in patients with HCC are scarce.

METHODS

Fifty-one consecutive patients with hepatocellular carcinoma were prospectively enrolled into this study and screened for malnutrition by anthropometric measurements, the MNA score, the NRS score, laboratory work-up, and BIA measurement. The results of the different screening tools were compared to each other and with the BIA assessment and correlated with the outcome of patients.

RESULTS

The calculation of a body mass index (BMI) was not suitable to identify malnourished patients with HCC. The MNA identified 19, the NRS score 17 patients at a risk for malnutrition. BIA revealed a reduction in relative body cell mass in 12 patients. Univariate Cox regression analyses identified tumor stage, MNA score, and phase angle obtained by BIA as significant factors with influence on survival. Multivariate analyses confirmed the phase angle at a cut-off of 4.8 to be an independent factor.

CONCLUSIONS

A significant proportion of patients with HCC is malnourished or at risk for malnutrition. Screening questionnaires and BIA measurement are superior to pure anthropometric measurements to identify the condition that negatively influences survival. The phase angle derived from body impedance analysis is an independent prognostic factor in patients with HCC.

摘要

背景与目的

营养不良是肝硬化患者、癌症患者常见且常被漏诊的病症,已有研究表明其会对患者的生存产生负面影响。目前常用的营养不良筛查工具,包括人体测量学指标或实验室参数,并不适用于伴有白蛋白减少和水肿等其他病理生理机制的肝硬化患者。关于 HCC 患者营养不良的患病率和预后影响的前瞻性数据较为缺乏。

方法

本研究前瞻性纳入了 51 例连续的肝细胞癌患者,通过人体测量学指标、MNA 评分、NRS 评分、实验室检查和 BIA 测量筛查营养不良。将不同筛查工具的结果相互比较,并与 BIA 评估结果及患者的预后相关联。

结果

计算体重指数(BMI)不适合识别患有 HCC 的营养不良患者。MNA 识别出 19 例、NRS 评分识别出 17 例有营养不良风险的患者。BIA 显示 12 例患者相对体细胞质量减少。单因素 Cox 回归分析确定肿瘤分期、MNA 评分和 BIA 获得的相位角是对生存有影响的显著因素。多因素分析证实,相位角在 4.8 的截点是一个独立的因素。

结论

相当一部分 HCC 患者存在营养不良或有营养不良风险。筛查问卷和 BIA 测量比单纯的人体测量学指标更能识别出对生存有负面影响的情况。来自体阻抗分析的相位角是 HCC 患者的一个独立预后因素。

相似文献

1
Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC).营养不良是肝细胞癌(HCC)患者的预后因素。
Clin Nutr. 2015 Dec;34(6):1122-7. doi: 10.1016/j.clnu.2014.11.007. Epub 2014 Nov 18.
2
A comparison of the malnutrition screening tools, MUST, MNA and bioelectrical impedance assessment in frail older hospital patients.衰弱老年住院患者的营养不良筛查工具 MUST、MNA 和生物电阻抗评估比较。
Clin Nutr. 2015 Apr;34(2):296-301. doi: 10.1016/j.clnu.2014.04.013. Epub 2014 May 2.
3
Computer-based malnutrition risk calculation may enhance the ability to identify pediatric patients at malnutrition-related risk for unfavorable outcome.基于计算机的营养不良风险计算可能会提高识别有营养不良相关不良结局风险的儿科患者的能力。
JPEN J Parenter Enteral Nutr. 2015 May;39(4):418-25. doi: 10.1177/0148607114529161. Epub 2014 Apr 9.
4
Serum albumin, subjective global assessment, body mass index and the bioimpedance analysis in the assessment of malnutrition in patients up to 15 years after liver transplantation.血清白蛋白、主观整体评估、体重指数和生物电阻抗分析在肝移植后 15 年内患者营养不良评估中的应用。
Clin Transplant. 2011 Jul-Aug;25(4):E396-400. doi: 10.1111/j.1399-0012.2011.01442.x. Epub 2011 Apr 3.
5
Nutrition status and pressure ulcer: what we need for nutrition screening.营养状况与压疮:营养筛查的需求
JPEN J Parenter Enteral Nutr. 2007 Jul-Aug;31(4):288-94. doi: 10.1177/0148607107031004288.
6
[Evaluation of nutritional Status in lung cancer using bio electrical impedance analysis and mini nutritional assessment].[使用生物电阻抗分析和微型营养评定法评估肺癌患者的营养状况]
Tunis Med. 2014 Dec;92(12):737-42.
7
Phase angle as a nutritional evaluation tool in all stages of chronic liver disease.作为慢性肝病各阶段营养评估工具的相位角
Nutr Hosp. 2012 Nov-Dec;27(6):2072-8. doi: 10.3305/nh.2012.27.6.6015.
8
Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of hemodialysis patients - a comparison with Mini Nutritional Assessment.生物电阻抗分析在评估血液透析患者营养状况中的可靠性——与微型营养评定法的比较
Transplant Proc. 2013;45(10):3485-8. doi: 10.1016/j.transproceed.2013.08.096.
9
Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.相位角是肌萎缩侧索硬化症患者生存的一个预后因素。
Amyotroph Lateral Scler. 2008 Oct;9(5):273-8. doi: 10.1080/17482960801925039.
10
Mini-nutritional assessment (MNA) is useful for assessing the nutritional status of patients with chronic obstructive pulmonary disease: a cross-sectional study.微型营养评定法(MNA)对评估慢性阻塞性肺疾病患者的营养状况有用:一项横断面研究。
COPD. 2014 Jun;11(3):325-32. doi: 10.3109/15412555.2013.863274. Epub 2014 Jan 29.

引用本文的文献

1
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.SII-PNI评分在经肝动脉化疗栓塞联合乐伐替尼及PD-1抑制剂治疗的不可切除肝癌中的预后价值
J Inflamm Res. 2025 Jun 10;18:7545-7557. doi: 10.2147/JIR.S520339. eCollection 2025.
2
Awareness and usage of a dietary guide by cancer patients and clinicians: a national survey study.癌症患者和临床医生对饮食指南的认知与使用情况:一项全国性调查研究。
Support Care Cancer. 2025 Jun 6;33(7):547. doi: 10.1007/s00520-025-09574-8.
3
Development and validation of a prealbumin-bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization.
用于经动脉化疗栓塞的中期肝细胞癌预后预测的前白蛋白-胆红素模型的开发与验证
Sci Rep. 2025 May 25;15(1):18147. doi: 10.1038/s41598-025-02960-6.
4
Impact of preoperative malnutrition, based on albumin level and body mass index, on operative outcomes in noncirrhosis patients with colorectal liver metastasis.基于白蛋白水平和体重指数的术前营养不良对非肝硬化结直肠癌肝转移患者手术结局的影响。
Front Surg. 2025 Mar 28;12:1512843. doi: 10.3389/fsurg.2025.1512843. eCollection 2025.
5
Long-term survival in a patient with ruptured advanced hepatocellular carcinoma treated with nutritional therapy combined with apatinib and camrelizumab: a case report.营养治疗联合阿帕替尼和卡瑞利珠单抗治疗晚期肝细胞癌破裂患者的长期生存:一例报告
Discov Oncol. 2025 Mar 23;16(1):378. doi: 10.1007/s12672-025-02099-w.
6
Comparison of Patient-Generated Subjective Global Assessment (PG-SGA) and Mini Nutritional Assessment (MNA) for nutritional assessment in hepatocellular carcinoma patients.患者主观全面评定法(PG-SGA)与微型营养评定法(MNA)在肝细胞癌患者营养评估中的比较
Support Care Cancer. 2025 Jan 21;33(2):116. doi: 10.1007/s00520-025-09176-4.
7
Assessment of Albumin-Incorporating Scores at Hepatocellular Carcinoma Diagnosis Using Machine Learning Techniques: An Evaluation of Prognostic Relevance.使用机器学习技术评估肝细胞癌诊断时的白蛋白整合评分:预后相关性评估
Bioengineering (Basel). 2024 Jul 28;11(8):762. doi: 10.3390/bioengineering11080762.
8
Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma.应用机器学习技术评估甲胎蛋白在肝细胞癌诊断中的应用。
Int J Mol Sci. 2024 Feb 7;25(4):1996. doi: 10.3390/ijms25041996.
9
Nutritional Assessment Tools for Patients with Cancer: A Narrative Review.癌症患者的营养评估工具:一项叙述性综述。
Curr Med Sci. 2024 Feb;44(1):71-80. doi: 10.1007/s11596-023-2808-4. Epub 2024 Jan 30.
10
Bioelectrical Impedance Analysis (BIA) for the Assessment of Body Composition in Oncology: A Scoping Review.生物电阻抗分析(BIA)在肿瘤学中评估身体成分的应用:范围综述。
Nutrients. 2023 Nov 15;15(22):4792. doi: 10.3390/nu15224792.